Granted Patent
Utility
US 6,451,006
· Confirmation No. 9114
METHOD FOR SEPARATING LAMELLAE
Inventor:
Josef Bille
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2014-03-17 | IMIS |
Miscellaneous Internal Document | 2 | View | |
| 2001-02-14 | TRNA |
Transmittal of New Application | 3 | View | |
| 2001-02-14 | SPEC |
Specification | 12 | View | |
| 2001-02-14 | CLM |
Claims | 5 | View | |
| 2001-02-14 | ABST |
Abstract | 1 | View | |
| 2001-02-14 | DRW |
Drawings-only black and white line drawings | 2 | View | |
| 2001-02-14 | OATH |
Oath or Declaration filed | 2 | View |
Inventors
Josef Bille
Heidelberg, GERMANY
Attorneys & Agents of Record
Classification
USPC
606/5
A61F9/00836
A61B2018/00642
A61F9/008
A61F9/00827
A61F9/013
A61F2009/00848
A61F2009/00872
A61F2009/00897
Prosecution
- Examiner
- DOLINAR, ANDREW M
- Art Unit
- 3747
- Customer No.
- 23862
- Docket No.
- 11270.25/NKN
- Confirmation No.
- 9114
Publication
- Pub. No.
- US20020111607A1
- Pub. Date
- 2002-08-15
Patent Term Adjustment
0days
No related applications found.
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, LTD.,
SALIX PHARMACEUTICALS, INC.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS IRELAND LIMITED
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH, CANADA INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMA POLAND SPOLKA Z ORGANICZONA ODPOWIEDZIALNOSCIA,
VALEANT SP. Z.O.O.
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
BAUSCH & LOMB INCORPORATED,
LABORATOIRE CHAUVIN S.A.S.,
TECHNOLAS PERFECT VISION GMBH,
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 045444/0634)
Recorded 2022-11-02
BAUSCH & LOMB INCORPORATED,
TECHNOLAS PERFECT VISION GMBH,
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES,
PF CONSUMER HEALTHCARE 1 LLC,
LABORATOIRE CHAUVIN S.A.S.
from
BARCLAYS BANK PLC
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 045444/0299)
Recorded 2022-10-26
from
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH HEALTH, CANADA INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA,
VALEANT PHARMACEUTICALS LUXEMBOURG S.À R.L.,
VALEANT SP. Z O. O.
INTELLECTUAL PROPERTY SECURITY AGREEMENT
Recorded 2019-07-03
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
from
ATON PHARMA, INC.,
BAUSCH & LOMB INCORPORATED,
BAUSCH & LOMB PHARMA HOLDINGS CORP.,
COMMONWEALTH LABORATORIES, LLC,
DOW PHARMACEUTICAL SCIENCES, INC.,
ECR PHARMACEUTICALS CO., INC.,
LABORATOIRE CHAUVIN S.A.S.,
MEDICIS PHARMACEUTICAL CORPORATION,
ONPHARMA INC.,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.,
SYNERGETICS USA, INC.,
TECHNOLAS PERFECT VISION GMBH,
VALEANT CANADA LP,
VALEANT PHARMA POLAND SP. Z O.O.,
VALEANT PHARMACEUTICALS INTERNATIONAL,
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.,
VALEANT PHARMACEUTICALS IRELAND LIMITED,
VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.,
VALEANT PHARMACEUTICALS NORTH AMERICA LLC,
WIRRA IP PTY LIMITED
SECURITY INTEREST
Recorded 2018-02-26
SECURITY INTEREST
Recorded 2017-07-19
SECURITY AGREEMENT
Recorded 2015-08-20
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2009-11-12
CHANGE OF NAME
Recorded 2009-08-10
CHANGE OF NAME
Recorded 2009-08-06
CHANGE OF NAME
Recorded 2009-08-05
from
BILLE, JOSEF
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2001-05-03
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- Patent No.
- US 6,451,006
- App. No.
- 09/783,665
- Filed
- 2001-02-14
- Granted
- 2002-09-17
- Pub. No.
- US20020111607A1
- Examiner
- DOLINAR, ANDREW M
- Art Unit
- 3747
- PTA
- 0 days
External Links